Category: Press Release - Page 95 - Psychedelic Alpha

Read more about the article European Patent Grant Strengthens Small Pharma’s Ketamine-Based Patent Portfolio for the Treatment of Depressive Disorders

European Patent Grant Strengthens Small Pharma’s Ketamine-Based Patent Portfolio for the Treatment of Depressive Disorders

Post published:October 25, 2021
Post category:Press Release

Read more about the article MindMed CMO to Chair Digital Biomarkers Summit

MindMed CMO to Chair Digital Biomarkers Summit

Post published:October 25, 2021
Post category:Press Release

Read more about the article Beckley Psytech Announces First Cohort Dosed in Phase 1 Clinical Trial Assessing Safety and Tolerability of Intranasal 5-MeO-DMT

Beckley Psytech Announces First Cohort Dosed in Phase 1 Clinical Trial Assessing Safety and Tolerability of Intranasal 5-MeO-DMT

Post published:October 25, 2021
Post category:Press Release

Read more about the article Small Pharma Granted Fast-Track Designation From U.K. Regulator for DMT-Assisted Therapy for Major Depressive Disorder

Small Pharma Granted Fast-Track Designation From U.K. Regulator for DMT-Assisted Therapy for Major Depressive Disorder

Post published:October 21, 2021
Post category:Press Release

Numinus Advances Phase 1 Trial on Proprietary Psilocybin Product

Post published:October 20, 2021
Post category:Press Release

Read more about the article Open-label study of COMP360 psilocybin therapy for depression in cancer patients demonstrates feasibility of simultaneous psilocybin administration in small groups

Open-label study of COMP360 psilocybin therapy for depression in cancer patients demonstrates feasibility of simultaneous psilocybin administration in small groups

Post published:October 20, 2021
Post category:Press Release

Read more about the article Tryp Therapeutics Reports Clinical Hold on Proposed Phase 2a Study in Eating Disorders

Tryp Therapeutics Reports Clinical Hold on Proposed Phase 2a Study in Eating Disorders

Post published:October 20, 2021
Post category:Press Release

Read more about the article Mycrodose Therapeutics and Nova Mentis Announce LOI to Co-Develop Advanced Drug Delivery System

Mycrodose Therapeutics and Nova Mentis Announce LOI to Co-Develop Advanced Drug Delivery System

Post published:October 19, 2021
Post category:Press Release

Read more about the article Field Trip Health Ltd. Continues Expansion With Psychedelic-Assisted Therapy Centers in Seattle, Vancouver and Fredericton

Field Trip Health Ltd. Continues Expansion With Psychedelic-Assisted Therapy Centers in Seattle, Vancouver and Fredericton

Post published:October 19, 2021
Post category:Press Release

Read more about the article Psyched Wellness Announces Preliminary Data Showing Potential New Functional Property and Health Benefit of Amanita Muscaria Mushroom (AME-1) To Inhibit Human Mast Cell Activation

Psyched Wellness Announces Preliminary Data Showing Potential New Functional Property and Health Benefit of Amanita Muscaria Mushroom (AME-1) To Inhibit Human Mast Cell Activation

Post published:October 19, 2021
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.